VYCO — Vycor Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $2.87m
- $3.78m
- $1.46m
- 65
- 63
- 40
- 57
Annual cashflow statement for Vycor Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.796 | -0.822 | -0.436 | -0.405 | -0.07 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.55 | 0.473 | 0.232 | 0.199 | 0.011 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.184 | 0.042 | 0.156 | -0.073 | 0.027 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0.007 | -0.249 | 0.021 | -0.217 | 0.029 |
| Capital Expenditures | -0.058 | -0.062 | -0.038 | -0.003 | -0.009 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.01 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.058 | -0.052 | -0.038 | -0.003 | -0.009 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.04 | 0.287 | 0.062 | 0.166 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.014 | -0.015 | 0.045 | -0.054 | 0.02 |